4.7 Review

Analysis of nocebo effects of antiepileptic drugs across different conditions

Journal

JOURNAL OF NEUROLOGY
Volume 263, Issue 7, Pages 1274-1279

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00415-015-8018-7

Keywords

Antiepileptic drugs; Adverse effects; Meta-analysis; Placebo effects; Nocebo effects

Funding

  1. Ente Cassa di Risparmio di Firenze

Ask authors/readers for more resources

The aim of this study was to assess the nocebo effect in all randomised controlled trials (RCTs) exploring the effect of antiepileptic drugs (AEDs) in the clinical conditions in which these compounds have been studied with the exception of epilepsy. We searched for all double-blind, placebo-controlled trials performed in adult patients, testing AEDs in any clinical condition except epilepsy. The following data were extracted from the placebo arms: the number of randomized patients, the number of patients withdrawing because of adverse effects (AEs), and the number of patients with 11 predefined AEs (dizziness, ataxia/coordination abnormal, diplopia, somnolence, fatigue, headache, memory impairment, tremor, abnormal thinking, anxiety and depression). Outcome measures were the percentages of patients whithdrawing due to AEs and reporting the selected AEs. RCTs included in the analysis were grouped in six main categories of clinical conditions (pain, movement disorders, psychiatric disorders, substance abuse, obesity and binge eating disorders, and miscellanea). Proportions of patients with 95 % confidence intervals (CIs) have been calculated for all reported outcome measures. Thirteen AEDs were studied and the total number of selected RCTs was 157. Significant percentages of placebo-treated patients withdrawing due to AEs and with specific AEs were observed in several cases. Significant differences emerged across different conditions. Comparisons with results of a previous meta-analysis on all RCTs in patients with drug-resistant epilepsies showed that ataxia, diplopia and fatigue were significantly more frequent, and patients withdrawing were significantly less frequent, in placebo-treated epileptic patients. Significant differences have been identified in the AEDs-induced nocebo effect across different conditions. Placebo-treated epilepsy patients have significantly more frequent neurological AEs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neuroimaging

Locus Coeruleus magnetic resonance imaging in cognitively intact elderly subjects

Filippo Sean Giorgi, Francesco Lombardo, Alessandro Galgani, Hana Hlavata, Daniele Della Latta, Nicola Martini, Nicola Pavese, Irene Ghicopulos, Filippo Baldacci, Alessio Coi, Marco Scalese, Luca Bastiani, Petra Keilberg, Daniele De Marchi, Francesco Fornai, Ubaldo Bonuccelli

Summary: The study analyzed the locus coeruleus using MRI technology and found no age-related differences in a cohort of cognitively normal subjects aged 60-80 years. Consistent with recent post-mortem studies, it suggests that the MRI features of the locus coeruleus are not significantly affected by age in the 60-80 age range.

BRAIN IMAGING AND BEHAVIOR (2022)

Review Neurosciences

Cenobamate: A Review of its Pharmacological Properties, Clinical Efficacy and Tolerability Profile in the Treatment of Epilepsy

Maria Antonietta Barbieri, Emilio Perucca, Edoardo Spina, Paola Rota, Valentina Franco

Summary: Cenobamate is a new antiseizure medication used for the treatment of focal seizures in adults. Its mechanisms of action include enhancing the inactivated state of sodium channels and positive modulation of GABA(A) receptors. It has high oral bioavailability and a long half-life, allowing for once-daily dosing. However, it can cause drug-drug interactions due to its effects on various liver enzymes.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2023)

Article Neurosciences

Perspective on mTOR-dependent Protection in Status Epilepticus

Francesca Biagioni, Roberta Celli, Filippo Sean Giorgi, Ferdinando Nicoletti, Francesco Fornai

Summary: This article discusses the novel role of the piriform cortex in epileptic seizures and its modulation of AMPA receptors under the influence of mTORC1. The results show that the mTORC1 inhibitor rapamycin can mitigate the duration, severity, and brain damage of seizures.

CURRENT NEUROPHARMACOLOGY (2022)

Review Neurosciences

Biological Mechanism-based Neurology and Psychiatry: A BACE1/2 and Downstream Pathway Model

Harald Hampel, Giuseppe Caruso, Robert Nistico, Gaia Piccioni, Nicola B. Mercuri, Filippo Sean Giorgi, Fabio Ferrarelli, Pablo Lemercier, Filippo Caraci, Simone Lista, Andrea Vergallo

Summary: Comprehensive studies on cancer have led to the development of molecular pathway-based therapies that can be applied to different types of tumors. This paradigm shift in medicine has the potential to be applied to other medical fields, such as psychiatry and neurology. The emerging paradigm shift in neuroscience is illustrated by a review of translational studies on BACE and neuregulin, which are involved in various neurological and psychiatric diseases, showing a shared genetic/biological architecture among them.

CURRENT NEUROPHARMACOLOGY (2023)

Article Neurosciences

Noradrenaline and Seizures: A Perspective on the Role of Adrenergic Receptors in Limbic Seizures

Francesca Biagioni, Roberta Celli, Stefano Puglisi-Allegra, Ferdinando Nicoletti, Filippo Sean Giorgi, Francesco Fornai

Summary: This article investigates the role of beta(2)-adrenergic receptors (AR) in modulating limbic seizures within the anterior piriform cortex. The results show that stimulation of beta(2)-AR can prevent limbic seizures induced by bicuculline, while antagonism at beta(2)-AR worsens seizure severity and prolongs seizure duration. The study suggests that beta(2)-AR plays an anticonvulsant role in the anterior piriform cortex.

CURRENT NEUROPHARMACOLOGY (2023)

Article Geriatrics & Gerontology

Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST)

Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, Sara Casciato, Emanuele Cerulli Irelli, Valentina Chiesa, Filippo Dainese, Giovanni De Maria, Giuseppe Didato, Giovanni Falcicchio, Martina Fanella, Edoardo Ferlazzo, Massimo Gangitano, Filippo Sean Giorgi, Angela La Neve, Oriano Mecarelli, Elisa Montalenti, Alessandra Morano, Federico Piazza, Patrizia Pulitano, Pier Paolo Quarato, Federica Ranzato, Eleonora Rosati, Laura Tassi, Carlo Di Bonaventura

Summary: This study assessed the effectiveness and tolerability of adjunctive brivaracetam in older patients with epilepsy treated in a real-world setting. The results demonstrated that brivaracetam was efficacious and well-tolerated in older patients, making it a suitable therapeutic option for this population.

DRUGS & AGING (2022)

Article Clinical Neurology

Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia

Alessandro Galgani, Francesco Lombardo, Nicola Martini, Andrea Vergallo, Luca Bastiani, Harald Hampel, Hana Hlavata, Filippo Baldacci, Gloria Tognoni, Daniele De Marchi, Irene Ghicopulos, Sara De Cori, Francesca Biagioni, Carla Letizia Busceti, Roberto Ceravolo, Ubaldo Bonuccelli, Dante Chiappino, Gabriele Siciliano, Francesco Fornai, Nicola Pavese, Filippo Sean Giorgi

Summary: This study used LC-MRI to investigate the involvement of the pontine nucleus Locus Coeruleus (LC) in Alzheimer's disease progression and its association with prognosis and cognitive performance in amnestic Mild Cognitive Impairment. The findings suggest that reductions in LC-MRI parameters may be predictive of clinical progression in Mild Cognitive Impairment and support the role of LC degeneration in the continuum of Alzheimer's disease.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Neurosciences

Language-related motor facilitation in Italian Sign Language signers

Fabio Giovannelli, Alessandra Borgheresi, Giulia Lucidi, Martina Squitieri, Gioele Gavazzi, Antonio Suppa, Alfredo Berardelli, Maria Pia Viggiano, Massimo Cincotta

Summary: Linguistic tasks can increase the excitability of the primary motor cortex as measured by motor evoked potentials induced by transcranial magnetic stimulation. This study aimed to evaluate the effect of spoken language tasks on motor cortex excitability in hearing signers. The results showed that the excitability of the motor cortex was higher in signers during both linguistic and non-linguistic tasks compared to the control group.

CEREBRAL CORTEX (2023)

Article Endocrinology & Metabolism

Late-onset fabry disease due to the p.Phe113Leu variant: the first italian cluster of five families

Vittoria Cianci, Angelo Pascarella, Lucia Manzo, Sara Gasparini, Oreste Marsico, Anna Mammi, Carmelo Massimiliano Rao, Claudio Franzutti, Umberto Aguglia, Edoardo Ferlazzo

Summary: This study presents an in-depth phenotype description of a cluster of five families from Southern Italy with males carrying the GLA c.337T>C (p.Phe113Leu) pathogenic variant. The patients frequently exhibited cardiac manifestations, but also experienced neurological and renal complications.

METABOLIC BRAIN DISEASE (2023)

Article Chemistry, Medicinal

Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses

Paola Rota, Francesco Bonfante, Luigi Anastasia, Paolo La Rocca, Matteo Pagliari, Marco Piccoli, Federica Cirillo, Andrea Ghiroldi, Valentina Franco, Carlo Pappone, Pietro Allevi

Summary: Global infections with Paramyxoviridae viruses, such as NDV and hPIVs, are a serious threat to animal and human health. The development of an efficient experimental NDV host model (chicken) may help evaluate the efficacy of hPIVs-HN inhibitors. Newly synthesized sialic acid derivatives showed high neuraminidase inhibitory activity against NDV, with four molecules confirming their in vitro inhibitory activity and low toxicity.

ACS INFECTIOUS DISEASES (2023)

Article Biochemistry & Molecular Biology

Melatonin versus Sleep Deprivation for Sleep Induction in Nap Electroencephalography: Protocol for a Prospective Randomized Crossover Trial in Children and Young Adults with Epilepsy

Costanza Varesio, Valentina Franco, Ludovica Pasca, Massimiliano Celario, Cinzia Fattore, Guido Fedele, Paola Rota, Michela Palmisani, Valentina De Giorgis

Summary: Electroencephalography (EEG) is important for diagnosing epilepsy in children and supporting syndromic classification. This study aims to compare the effectiveness of melatonin and sleep deprivation in inducing sleep for EEG recordings in pediatric patients with epilepsy. A randomized crossover trial will be conducted with 30 patients receiving either 3-5 mg melatonin or sleep deprivation. The concentrations of melatonin and its metabolite will be measured using LC-MS, and the standardized sleep induction protocol will be established for pediatric EEG recordings.

METABOLITES (2023)

Review Neurosciences

Cultural Differences in Inhibitory Control: An ALE Meta-Analysis

Gioele Gavazzi, Chiara Noferini, Viola Benedetti, Maria Cotugno, Fabio Giovannelli, Roberto Caldara, Mario Mascalchi, Maria Pia Viggiano

Summary: Culture has a significant impact on attitudes, beliefs, and behaviors, influencing communication and decision-making. The debate over whether individuals from Eastern cultures have greater self-control abilities compared to those from Western cultures continues. Using fMRI, this study conducted a meta-analysis that analyzed 30 studies involving participants from both Western and Eastern countries, investigating their performance in Go-Nogo and Stop Signal Tasks. The findings revealed differences in brain activation patterns between Eastern and Western culture participants, with Eastern culture individuals showing higher activation in brain regions associated with proactive inhibitory control, while Western culture individuals relied more on reactive inhibitory brain regions during cognitive control tasks.

BRAIN SCIENCES (2023)

Review Clinical Neurology

Impulsivity Traits in Parkinson's Disease: A Systematic Review and Meta-Analysis

Fabio Giovannelli, Gioele Gavazzi, Chiara Noferini, Pasquale Palumbo, Maria Pia Viggiano, Massimo Cincotta

Summary: This systematic review and meta-analysis compared impulsivity between patients with Parkinson's disease (PD) and healthy controls, as well as between patients with PD with and without impulse control disorders (ICDs). The results showed that patients with PD had higher impulsivity scores, and patients with PD with ICDs had even higher scores.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Article Environmental Studies

Virtual Forest Environment Influences Inhibitory Control

Viola Benedetti, Gioele Gavazzi, Fiorenza Giganti, Elio Carlo, Francesco Riccardo Becheri, Federica Zabini, Fabio Giovannelli, Maria Pia Viggiano

Summary: Exposure to natural green environments, whether through visual media or in person, can bring numerous benefits to physical and mental health. In this study, we investigated the impact of viewing videos of urban or forest environments on inhibitory control and attention in people with or without a past COVID-19 infection. The results showed that exposure to forest videos improved the inhibitory component in both groups.
No Data Available